下肢周围神经阻塞对于患有急性分区综合征风险的患者
Jerry Jones1, Kevin Lee2, Madeline Jones3
1East Memphis Anesthesia Services, Department of Anesthesiology, University of Tennessee Health Science Center, Memphis, USA.
The Orthopedic clinics of North America
|September 17, 2023
概括
外周神经阻塞 (PNBs) 可能有助于早期诊断急性隔间综合征 (ACS),与对延迟诊断的担忧相反. 了解疼痛途径是优化风险患者护理的关键.
科学领域:
- 整形外科 整形外科 整形外科
- 疼痛管理 疼痛管理
- 手术并发症 手术并发症
背景情况:
- 晚期诊断急性隔间综合征 (ACS) 会导致严重的并发症.
- 典型的ACS诊断迹象和症状具有较低的敏感性.
- 怀疑包括止痛药在内的各种疼痛管理技术会延迟ACS诊断.
研究的目的:
- 调查外围神经阻塞 (PNBs) 与ACS延迟诊断之间的潜在联系.
- 探索PNB是否可以促进早期ACS诊断.
- 了解 nociceptive 途径在 ACS 中区分缺血性和炎症性疼痛中的作用.
主要方法:
- 审查关于止痛方式和ACS诊断的现有文献.
- 对外围神经阻塞对诊断时间线的影响的证据分析.
- 在缺血和炎症条件下探索疼痛传播的神经生理学的基础.
主要成果:
- 目前有限的证据将外围神经阻塞 (PNB) 与延迟急性隔间综合征 (ACS) 诊断联系起来.
- 新出现的证据表明,PNBs实际上可能会促进更早的ACS诊断.
- 通过独特的痛感途径传递疼痛信号的差异可能解释了这种效应.
结论:
- 周围神经阻塞 (PNBs) 可能不会延迟,但可能会改善急性隔间综合征 (ACS) 的诊断.
- 需要进一步的研究来阐明PNBs和疼痛通路在ACS诊断中的作用.
- 合作努力对于优化对容易感染ACS.患者的护理至关重要.
相关概念视频
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
457
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
457
Peripheral Artery Disease V: Postoperative Nursing Management
12
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
12
Peripheral Artery Disease IV: Nursing Management
12
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
12
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
15
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
15
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Depolarizing Blockers: Pharmocokinetics
352
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
352


